News

Mental health: it is time to do what is needed now or it will be more extensive and expensive later.

Daniel Morehead, MD, explores the resurgence of antipsychiatry sentiments and the importance of advocating for mental health amid rising skepticism.

Explore transformative memoirs and insights on estrangement in these 2 brief book reviews.

How can we apply the principles of redemption in psychiatry?

What role should performance enhancers and even AI play in psychiatry and human interactions?

Daniel Morehead, MD, critiques the discourse around antidepressants, urging a balanced view of their benefits and risks while addressing patient concerns.

Effective safety plans are an important measure for suicide prevention. Emphasizing early intervention and structured support can reduce risks and save lives.

Euthanasia risks becoming a symptom of burnout.

Taking a page from the Olympics, psychiatry needs to work faster, higher, and stronger--together.

Although medical ethics prioritizes the patient, should the clinician get more equal consideration?

Cultivating hope in therapy enhances resilience and empowers patients to overcome mental health challenges and achieve their goals.

Championing diverse voices: check out our June theme! We want to hear about your insights, tips, and case studies.

Discover key insights from the APA Annual Meeting, highlighting advancements in lifestyle psychiatry, ADHD treatment, and innovative suicide prevention models.

Check out the pipeline updates from May!

Psychiatric professionals express concern over the impact of federal changes on diversity, equity, and inclusion programs in mental health care.

Recent research reveals dopamine partial agonists significantly reduce somnolence in major depressive disorder and schizophrenia compared with D2 receptor antagonists.

In this CME article, learn more about the essential role of MAOIs in treating resistant depression and anxiety.

Cariprazine shows promise as a long-term adjunctive treatment for anhedonia in major depressive disorder, according to new poster data presented at the ASCP Annual Meeting.

Neurocrine Biosciences reveals promising phase 2 results for NBI-1117568, a novel treatment for schizophrenia, showing significant symptom improvement over placebo.

How do psychiatrists feel about the current polycrises? “Overwhelmed.”

Vincenzo Di Nicola discusses the importance of pluralism in social psychiatry and the need for culturally relevant psychotherapy at the 2025 APA Annual Meeting.

Learn more about the critical link between early adversity and psychosis, and the need for targeted interventions and preventive measures.

Online dating transforms connections but often leads to loneliness and mental health issues. How can we encourage safer, more meaningful interactions?

Explore the complex role of dopamine in schizophrenia, its impact on symptoms, and potential therapeutic advancements.

Psychiatrists united in Los Angeles for a rally, advocating for mental health funding amidst growing concerns over service cuts and societal challenges.

Early intervention in schizophrenia enhances recovery, reduces symptoms, and improves quality of life through coordinated specialty care programs across the US.

Dr Goldberg and Dr Anita share previews of the upcoming ASCP Annual Meeting in Scottsdale, Arizona.

In this Special Report, explore groundbreaking insights on schizophrenia treatment, early intervention strategies, and the impact of childhood trauma on psychosis.

Explore the urgent need for collaboration in mental health to combat societal crises and promote prosocial behavior for a healthier future.

Poster presented at the APA Annual Meeting finds zuranolone effective for anhedonia associated with PPD.